Did You Know...
...that one person who claimed to be the inventor of the television is Russian emigre Vladimir Zworykin? In 1929 David Sarnoff, founder of RCA, asked Zworykin what it would take to develop TV for commercial use. He said: a year and a half and $100,000. In reality, it took 20 years and $50 million! Before his death in 1982 at the age of 92, Zworykin said of his invention: "The technique is wonderful. It is beyond my expectations. But the programs! I would never let my children even come close to this thing."
PatentStorm News
Make the Most of PatentStorm
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest patents by subscribing to an RSS feed.
Got questions? Ask a Patent Expert!
Registered users: Manage your profile, comments and alerts.
| Number | Title | Issue Date |
| 7357949 | Encapsulated inorganic antimicrobial additive for controlled release The invention relates to a microcapsule comprising an inorganic antimicrobial agent coated with a hydrophilic polymer. The hydrophilic polymer is able to absorb sufficient water as to enable the action of the encapsulated antimicrobial agent. These microcapsules are... | 04/15/2008 |
| 7354605 | Antimicrobial medical device According to the present invention there are provided antimicrobial catheters and other medical devices having controlled release of an antimicrobial metal or metal ion. Specifically, antimicrobial catheters and other medical devices manifest antimicrobial propertie... | 04/08/2008 |
| 7354609 | Medication for hyperacidity A medication for hyperacidity is provided and consists of seven ingredients to bring about improvements in a patient with hyperacidity. The ingredients are soybeans, vegetables, milk, butter fats, whole wheat, fruits and magnesium citrate. ... | 04/08/2008 |
| 7312243 | Materials and methods for treatment of gastrointestinal disorders The subject invention pertains to materials and methods for the prevention and treatment of gastrointestinal diseases, including inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. Therapeutic compositions of the invention include composition... | 12/25/2007 |
| 7135197 | Stable pharmaceutical composition useful for treating gastrointestinal disorders The present invention provides a pharmaceutical composition comprising at least one pharmaceutically acceptable bismuth-containing compound, at least one pharmaceutically acceptable non-clay-derived suspending agent, and water. The suspension exhibits reduced upward... | 11/14/2006 |
| 7056948 | Use of odor reducing and cross-adapting agents to reduce animal waste malodors Methods and compositions for reducing animal waste malodor using agents and cross-adapting agents are described. ... | 06/06/2006 |
| 7053073 | Treatment for reactive arthritis or bursitis A treatment for conditions in human beings associated with either or both reactive arthritis or bursitis comprising a combination of valacyclovir hydrochloride, minocycline hydrochloride, and metronidazole. ... | 05/30/2006 |
| 7033614 | Bismuth oxychloride compositions and methods of rinsing A rinse-off composition comprising in percent by weight 0.10–10.00 of a dispersion of bismuth oxychloride 3.50–90.00 of a surfactant, 0.001–0.050 of a dye, 3.00–15.00 of an emollient and 10.00–80.00 of water; said dispersion of bismuth oxychloride containi... | 04/25/2006 |
| 7030147 | Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative Epothilone derivatives are co-administered with an antidiarrheal agent, e.g., a DPP-IV inhibitor, in the treatment of a proliferative disease. ... | 04/18/2006 |
| 7008647 | Treatment of acne The invention relates to the use of one or more antimicrobial metals selected from silver, gold, platinum, and palladium but most preferably silver, preferably formed with atomic disorder, and preferably in a nanocrystalline form, for the treatment of a acne. The na... | 03/07/2006 |
| 6989156 | Therapeutic treatments using the direct application of antimicrobial metal compositions Therapeutic treatments using the direct application of selected structures of antimicrobial metals in free-standing powder form, solution form and/or suspension form in therapeutically effective amounts. The selected structures of antimicrobial metals serve as an an... | 01/24/2006 |
| 6939568 | Treatment of inflammatory skin conditions The invention relates to the use of one or more antimicrobial metals, most preferably silver, preferably formed with atomic disorder, and preferably in a nanocrystalline form, for the treatment of inflammatory skin conditions. The nanocrystalline antimicrobial metal... | 09/06/2005 |
| 6929926 | Composition for the detection of gastrointestinal disorders A system and method for detecting bacterial infections in the gastrointestinal tract is disclosed. In one embodiment, the system includes a first composition separated from a second composition. The first composition contains urea in powdered form. The second compos... | 08/16/2005 |
| 6905711 | Antimicrobial agents, products incorporating said agents and methods of making products incorporating antimicrobial agents An antimicrobial agent includes an oligodynamic metal ion in a hydrophilic polymer binder or carrier. According to a presently preferred embodiment, the metal ion is silver and the hydrophilic polymer is polyurethane. According to a method of the invention, the anti... | 06/14/2005 |
| 6902738 | Topical oral dosage forms containing bismuth compounds Topical oral dosage forms containing bismuth compounds are described, which are useful for treating H. pylori and other bacterial infections that cause gastrointestinal disorders and halitosis, as well as for treating ocular and dermal wounds. Methods of empl... | 06/07/2005 |
| 6881424 | Highly acidic metalated organic acid A highly acidic metalated organic acid composition and its preparation. The acidic composition can be prepared by mixing a monovalent or polyvalent cation and an organic acid in the presence of a strong oxyacid, wherein the resultant acidic composition is less corro... | 04/19/2005 |
| 6764692 | Method to treat laminitis and reduce dietary intake for horses A method of treating laminitis in a horse is disclosed, comprising administering to the horse a naturally chelated trace mineral composition; promoting healthy skin, hair and hoof tissue. A method of reducing dietary intake is also disclosed, comprising administerin... | 07/20/2004 |
| 6723350 | Lubricious coatings for substrates The invention provides methods and kits to form water swellable gel coatings, preferably lubricious coatings, on substrates, and coated substrates thus formed. The coatings contain one or more antimicrobial metals formed with atomic disorder, together with one or mo... | 04/20/2004 |
| 6669966 | Compositions for facilitating skin growth and methods and articles using same Skin-growth-enhancing compounds and compositions including a therapeutically effective amount of at least one electron active compound, or a pharmaceutically acceptable derivative thereof, that has at least two polyvalent cations, at least one of which ha... | 12/30/2003 |
| 6645531 | Multivalent electron active compositions and methods of making and using same The present invention is directed to pharmaceutical compositions that include a therapeutically effective amount of at least one electron active compound, or a pharmaceutically acceptable derivative thereof, that has at least two polyvalent cations, at le... | 11/11/2003 |
| 6630172 | Microbicidal composition containing potassium sodium tartrate Disinfectant formulations are described which are preferably ecologically friendly and non-toxic to mammals and plants, and are highly effective against a broad spectrum of detrimental pathogenic microorganisms. The microbicidal formulation contains compl... | 10/07/2003 |
| 6616938 | Method of making chewing gum containing colloidal bismuth subcitrate The invention provides a method of making a chewing gum composition containing a water soluble bulk portion, a water insoluble chewing gum base portion, a flavoring agent, and bismuth-containing compounds. The invention provides a method of making a bismu... | 09/09/2003 |
| 6582719 | Combinations of antiseptic and antibiotic agents that inhibit the development of resistant microorganisms The present invention relates to compositions comprising a combination of one or more antiseptic and an antibiotic. It is based, at least in part, on the discovery that such combinations tend to deter the formation of antibiotic-resistant organisms. In pr... | 06/24/2003 |
| 6579541 | Oxidative fluorinator compounds as antimicrobials The invention relates to a method and composition for destroying or inhibiting proliferation of microbes using oxidative fluorinator compounds. Fluoride salts that do not dissociate completely in aqueous solutions, such as tri- or tetravalent transition m... | 06/17/2003 |
| 6565895 | Bismuth compounds for the treatment and prevention of mucositis The invention relates to the unexpected discovery that bismuth-containing compounds are effective in the treatment of oral mucositis in a mammal. Thus, the invention relates, in one aspect to a method of treating oral mucositis comprising administering an... | 05/20/2003 |
| 6541455 | Methods and kits for removing, treating, or preventing lice with driable pediculostatic agents Methods and kits for removing, treating or preventing head lice infestations in patients in need of such treatment are disclosed and include topically applying to the lice-infested area an effective amount of a driable pediculostatic agent for a time suff... | 04/01/2003 |
| 6521265 | Method for applying a blood clotting agent A method of arresting the flow of blood and other protein containing body fluids flowing from an open wound and for promoting wound healing. In the method, a substantially anhydrous compound of a salt ferrate is provided for a unique use which, when hydra... | 02/18/2003 |
| 6489317 | Method for eradication of Helicobacter pylori The invention provides methods for the treatment and/or prevention of recurrence of a gastrointestinal disorder associated with Helicobacter pylori in a patient requiring said treatment and/or prevention, which comprise administering to the patient a ther... | 12/03/2002 |
| 6485755 | Methods of using electron active compounds for managing cancer The present invention provides methods for preventing, treating, and/or managing one or more cancerous conditions in a patient, such as a human. A multivalent metal oxide, such as Ag(I,III), Cu(I,III), Pr(III,IV), and Bi(III,V) oxides or a pharmaceuticall... | 11/26/2002 |
| 6426085 | Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis This invention provides for a method for treatment of corneal and dermal wounds by administering bismuth compounds in topical dosage forms. Bismuth compounds cause stimulation of release of growth factors in damaged tissue to promote regeneration of epith... | 07/30/2002 |
| 6379651 | Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases The invention relates to concomitant treatment with bismuth compounds, other antibacterial compounds, and/or antibiotics in oral-topical and peroral dosage forms to eradicate H. pylori from its niches both in the dental plaque and in the gastric mucosa in... | 04/30/2002 |
| 6372784 | Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds This invention provides for a method for treatment of corneal and dermal wounds by administering bismuth compounds in topical dosage forms. Bismuth compounds cause stimulation of release of growth factors in damaged tissue to promote regeneration of epith... | 04/16/2002 |
| 6362169 | Antibacterial compositions with synergistic effect, drugs and remedies for digestive diseases containing the same, process for the production thereof and preparations associated therewith Antibacterial compositions comprising (1) a rifamycin derivative represented by the formula (I) or its physiologically acceptable salt, and (2) a proton pump inhibitor (a) or a bismuth preparation (b) wherein the components (1) and (2) are used in such am... | 03/26/2002 |
| 6303581 | Methods and kits for removing, treating, or preventing lice with driable pedicul ostatic agents Methods and kits for removing, treating or preventing head lice infestations in patients in need of such treatment are disclosed and include topically applying to the lice-infested area an effective amount of a driable pediculostatic agent for a time suff... | 10/16/2001 |
| 6271256 | Methods for controlling gram negative bacteria in mammals with bicyclo spiroether compounds Methods for controlling growth of gram negative bacteria, such as Helicobacter pylori, which are agents associated with disorders of the gastrointestinal tract of a mammal are described. They include administering a therapeutically effective amount of a p... | 08/07/2001 |
| 6265384 | Methods and kits for removing, treating, or preventing lice with driable pediculostatic agents Methods and kits for removing, treating or preventing head lice infestations in patients in need of such treatment are disclosed and include topically applying to the lice-infested area an effective amount of a driable pediculostatic agent for a time suff... | 07/24/2001 |
| 6248718 | Lesion-directed dry dosage forms of antibacterial agents for the treatment of acute mucosal infections of the oral cavity The invention provides a medicament for topically treating acute bacterial infections in the oral mucosa, and methods of use. The medicament comprises a dry dosage (such as a troche or powder) of one or more antibacterial agents and, preferably, one or mo... | 06/19/2001 |
| 6248371 | Metal/thiol biocides Methods for administering a composition comprising bismuth and a thiol-containing complexing agent as a bacteriocidal, bacteriostatic, antifungal or antiviral agent are provided.... | 06/19/2001 |
| 6232341 | Topical pharmaceutical compositions for healing wounds The present invention provides a topical pharmaceutical composition for wound healing, which comprises (a) borneol and (b) bismuth subgallate in effective amounts. The topical pharmaceutical composition is capable of enhancing wound healing with minor irr... | 05/15/2001 |
| 6203807 | Cosmetic composition with a lipophilic continuous phase containing a novel pigment A cosmetic composition having a lipophilic continuous phase, in particular make-up compositions, containing a novel yellow pigment of intense, saturated color, which does not generate free radicals. This novel pigment is a bismuth vanadate of formula BiVO... | 03/20/2001 |